A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters.

Fagre AC, Manhard J, Adams R, Eckley M, Zhan S, Lewis J, Rocha SM, Woods C, Kuo K, Liao W, Li L, Corper A, Challa D, Mount E, Tumanut C, Tjalkens RB, Aboellail T, Fan X, Schountz T

Open source

DOI: 10.3389/fimmu.2020.614256
Published: 2020
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2020.614256,
  title = {A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters.},
  author = {Fagre AC and Manhard J and Adams R and Eckley M and Zhan S and Lewis J and Rocha SM and Woods C and Kuo K and Liao W and Li L and Corper A and Challa D and Mount E and Tumanut C and Tjalkens RB and Aboellail T and Fan X and Schountz T},
  year = {2020},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2020.614256},
  url = {https://doi.org/10.3389/fimmu.2020.614256}
}

RIS

TY  - JOUR
TI  - A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters.
AU  - Fagre AC
AU  - Manhard J
AU  - Adams R
AU  - Eckley M
AU  - Zhan S
AU  - Lewis J
AU  - Rocha SM
AU  - Woods C
AU  - Kuo K
AU  - Liao W
AU  - Li L
AU  - Corper A
AU  - Challa D
AU  - Mount E
AU  - Tumanut C
AU  - Tjalkens RB
AU  - Aboellail T
AU  - Fan X
AU  - Schountz T
PY  - 2020
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2020.614256
UR  - https://doi.org/10.3389/fimmu.2020.614256
ER  -

APA

AC, F., J, M., R, A., M, E., S, Z., J, L., SM, R., C, W., K, K., W, L., L, L., A, C., D, C., E, M., C, T., RB, T., T, A., X, F., & T, S. (2020). A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2020.614256

Source records

pubmed · retrieved 2026-09-27T01:43:22.934Z